ERBB2 and invasive breast carcinoma: The present study aims to provide additional clinical references by conducting a retrospective analysis of 166 cases of invasive breast cancer patients, focusing on the heterogeneity in ER, PR, and HER2 expression between primary tumors and metastases, as well as the impact of this variation on prognosis and individualized treatment.